Actinium Pharmaceuticals's total assets for Q4 2025 were $51.77M, a decrease of -7.79% from the previous quarter. ATNM total liabilities were $43.94M for the fiscal quarter, a 3.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.